XARELTO 2.5 mg, film-coated tablet 100 tablets
Brand page: Xarelto (rivaroxaban) — all forms and strengths in France
Active ingredients: Rivaroxaban
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XARELTO 2,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 100 plaquette(s) thermoformée(s) polypropylène aluminium de 1 comprimé(s)
- Marketing authorisation holder
- BAYER AG (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63415127CIP75856332CIP133400958563324Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVAROXABANcomprimé | 2,50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.